BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22369941)

  • 1. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.
    Xiao N; Chen S; Ma Y; Qiu J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochem Biophys Res Commun; 2012 Mar; 419(3):567-72. PubMed ID: 22369941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
    Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
    Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a halogenated G-quadruplex ligand from the pyridine dicarboxamide series on the terminal sequence of XpYp telomere in HT1080 cells.
    Sidibe A; Hamon F; Largy E; Gomez D; Teulade-Fichou MP; Trentesaux C; Riou JF
    Biochimie; 2012 Dec; 94(12):2559-68. PubMed ID: 22796264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands.
    Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3414-7. PubMed ID: 19477640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.
    Zaug AJ; Podell ER; Cech TR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10864-9. PubMed ID: 16043710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
    Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
    Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fission yeast telomeric DNA binding protein Pot1 has the ability to unfold tetraplex structure of telomeric DNA.
    Torigoe H
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1255-60. PubMed ID: 18066763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
    He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraplex structure of fission yeast telomeric DNA and unfolding of the tetraplex on the interaction with telomeric DNA binding protein Pot1.
    Torigoe H; Furukawa A
    J Biochem; 2007 Jan; 141(1):57-68. PubMed ID: 17158862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer.
    Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H
    Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraplex structure of fission yeast telomeric DNA and its unfolding by the interaction with telomeric DNA binding protein Pot1.
    Furukawa A; Torigoe H
    Nucleic Acids Symp Ser (Oxf); 2005; (49):63-4. PubMed ID: 17150634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between tetraplex structure of mouse telomeric DNA and telomeric DNA binding domains of mouse telomere binding protein Pot1.
    Kaneda K; Torigoe H
    Nucleic Acids Symp Ser (Oxf); 2009; (53):245-6. PubMed ID: 19749352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfolding of tetraplex structure of mouse telomeric DNA by the interaction with mouse telomeric DNA binding protein Pot1.
    Torigoe H; Kaneda K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):249-50. PubMed ID: 18029680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.